newsfilter
← Latest News
PR Newswire·

Mountain Valley MD files patent and begins pre-clinical trials to enter USD $100 billion cancer drug market

VANCOUVER, BC, May 4, 2021 /PRNewswire/ - Mountain Valley MD (CSE:MVMD) (FRA: 20MP) (OTCQB:MVMDF) announced it has filed a novel cancer adjuvant patent related to breast cancer, metastatic melanoma, and lung carcinoma.